TheraRadar
← Back
Data updated: Jul 17, 2026

GEMINI LABS LLC

Specialty
Pharmaceuticals

GEMINI LABS LLC is a specialty pharmaceutical company with 1 FDA-approved products.

1997
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

GEMINI LABS LLC's Key Drugs

GEMINI LABS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

GEMINI LABS LLC's Recent FDA Approvals

New NDA/BLA approvals for GEMINI LABS LLC over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

GEMINI LABS LLC's Therapeutic Areas

Disease areas where GEMINI LABS LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

GEMINI LABS LLC Pipeline Snapshot

Active clinical trials for GEMINI LABS LLC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling